| |
| About CLDF | Mission Statement |
| The foundation's goal is to provide health
professionals with the most current education
and information on CLD. |
| |
| Educational programs are designed so
physicians, nurses, nurse practitioners,
physician assistants, and pharmacists have
information about the latest medical
developments and their implications for patient
management. Information is drawn from academia,
medical societies, government health agencies,
and the pharmaceutical industry, and is
integrated into balanced, up-to-date educational
programs and materials for health professionals.
|
| |
| The Chronic Liver Disease Foundation is a
nonprofit 501(c)(3) educational organization
dedicated to increasing awareness of the effect
of chronic liver disease (CLD) in the United
States. All grants awarded to CLDF are restricted to support our programs and are not used for salaries and general administrative expenses of the Chronic Liver Disease Foundation. |
| |
| Overview |
| The Chronic Liver Disease Foundation
provides education to the medical community
concerning a disease that affects an estimated
40 million people in the United States. |
| |
| The most common types of CLD in the United
States include nonalcoholic fatty liver disease,
nonalcoholic steatohepatitis, chronic hepatitis
C, alcoholic liver disease, chronic hepatitis B,
and hemochromatosis. |
| |
| For all age groups, CLD was the 12th leading
cause of death in the year 2000, accounting for
more than 25,000 deaths. In the 45 to 54 age
group, CLD and cirrhosis were the 4th leading
cause of death in males, and the 6th leading
cause of death in females. |
| |
| More than 17,000 patients are currently on
the liver transplant waiting list, yet just over
5000 patients receive liver transplants each
year. |
| |
| New therapies continue to evolve in the
treatment of CLD. New molecular testing
techniques aid in the detection and therapeutic
monitoring of liver disease. Recombinant
vaccines have been developed for 2 common types
of hepatitis. And, in those cases where liver
disease has progressed to a point where
treatment is no longer effective, liver
transplant has become a more viable option, in
most instances, than it was just a decade ago. |
| |
| The Chronic Liver Disease Foundation is
committed to providing healthcare professionals
with the latest developments in understanding
liver disease. Educational opportunities are
offered in a variety of formats including an
interactive Web site, live meetings,
teleconferences, print pieces, audiocassettes,
and CD-ROMS. |
| |
| |
|
|
|
|
